Hostname: page-component-5c6d5d7d68-tdptf Total loading time: 0 Render date: 2024-08-13T23:47:52.889Z Has data issue: false hasContentIssue false
  • English
  • Français

Interactions Between Self-Exposure and Alprazolam in the Treatment of Agoraphobia Without Current Panic: An Exploratory Study

Published online by Cambridge University Press:  16 June 2009

Enrique Echeburúa ,
Paz De Corral ,
Elvira García Bajos  and
Mercedes Borda
Enrique Echeburúa
Affiliation:
Universidad del País Vasco, España
Paz De Corral
Affiliation:
Universidad del País Vasco, España
Elvira García Bajos
Affiliation:
Universidad del País Vasco, España
Mercedes Borda
Affiliation:
Universidad del País Vasco, España
Get access Rights & Permissions [Opens in a new window]

Abstract

The aim of this work was to test the comparative efficacy of four therapeutic modalities (self-exposure, self-exposure + Alprazolam, Alprazolam, and self-exposure + placebo) and also to determine the combined effects of self-exposure with Alprazolam and self-exposure with placebo in the treatment of agoraphobia without current panic. The sample consisted of 31 patients selected according to DSM-III-R criteria. A multigroup experimental design with repeated measures of assessment (pre-treatment, post-treatment and 1, 3 and 6-month follow-up) was used. The results indicated that there was a similar therapeutic improvement (in about 75% of the cases) between pre- and post-treatment in all therapeutic modalities, except for the Alprazolam group, where improvement did not take place, was rather weak or tended to fade as time passed. This improvement increased at the follow-ups in the self-exposure + placebo group, remained stable in the self-exposure group, and was irregular or fairly unpredictable in the self-exposure + Alprazolam group. There was a positive combined action between self-exposure and placebo and a negative interaction between self-exposure and Alprazolam. The highest relapse rate appeared in the therapeutic modalities where the active drug was administered. The intratreatment evolution was faster in the self-exposure group than in the others, but it tended to remain stable in the second part of the therapy. It is therefore concluded that the efficacy of self-exposure therapy may be the same if reduced to half the number of sessions. Finally, several topics that may contribute to future research in this field are commented upon.

Type
Research Article
Information
Behavioural and Cognitive Psychotherapy , Volume 21 , Issue 3 , July 1993 , pp. 219 - 238
Copyright
Copyright © British Association for Behavioural and Cognitive Psychotherapies 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agras, W.S., Chapin, H.N. and Oliveau, D.C. (1972). The natural history of phobia: course and prognosis. Archives of General Psychiatry 26, 315–317.CrossRefGoogle ScholarPubMed
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd. ed. rev.). Washington: APA.Google Scholar
Aronson, T.A. (1987). A naturalistic study of imipramine in panic disorder and agoraphobia. American Journal of Psychiatry 144, 1014–1019.Google ScholarPubMed
Ballenger, J.C., Burrows, G.D. and Dupont, R.L. (1988). Alprazolam in panic disorder and agoraphobia: I. Efficacy in short-term treatment. Archives of General Psychiatry 45, 413–422.CrossRefGoogle ScholarPubMed
Burns, L.E., Thorpe, G.L., Cavallaro, A. and Gossling, J. (1986). Agoraphobia 8 years after behavioral treatment. Behavior Therapy 17, 580–591.CrossRefGoogle Scholar
Chambless, D., Foa, E.B., Groves, G.A. and Goldstein, A.J. (1979). Flooding with brevital in the treatment of agoraphobia: counterreflective? Behaviour Research and Therapy 17, 243–251.CrossRefGoogle Scholar
Clum, G.A. (1986). Drugs vs psychologically based interventions in the treatment of panic disorders.Paper presented at the American Psychological Association,Washington, DC.Google Scholar
Cohen, S., Monteiro, W. and Marks, I. (1984). Two-year follow-up of agoraphobics after exposure and imipramine. British Journal of Psychiatry 144, 276–281.CrossRefGoogle ScholarPubMed
Craske, M.G., Sanderson, W.D. and Barlow, D.H. (1987). How do desynchronous response systems relate to the treatment of agoraphobia: a follow-up evaluation. Behaviour Research and Therapy 25, 117–122.CrossRefGoogle Scholar
Echeburúa, E. and Corral, P. (1990a). Escala de Adaptación (in press).Google Scholar
Echeburúa, E. and Corral, P. (1990b). Inventario de Agorafobia (in press).Google Scholar
Echeburúa, E., Corral, P., García, E. and Borda, M. (1991). La autoexposición y las benzodiacepinas en el tratamiento de la agorafobia sin historia de trastorno de pánico: resultados a largo plazo. Análisis y Modificatión de Conducta 17, 969–991.Google Scholar
Emmelkamp, P.M.G. and Kuipers, A.C.M. (1979). Agoraphobia: a follow-up study 4 years after treatment. British Journal of Psychiatry 134, 352–355.CrossRefGoogle Scholar
Foa, E.B. and Kozak, M. (1986). Emotional processing of fear. Psychological Bulletin 99, 20–35.CrossRefGoogle ScholarPubMed
Ghosh, A. and Marks, I. (1987). Self-treatment of agoraphobia by exposure. Behavior Therapy 18, 3–17.CrossRefGoogle Scholar
Hand, I. (1986). In Hand, I. and Wittchen, H.U. (Eds) Panic and Phobias. New York: Springer-Verlag.CrossRefGoogle Scholar
Hafner, H. and Marks, I. (1976). Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. Psychological Medicine 6, 71–88.CrossRefGoogle ScholarPubMed
Holden, A., O'Brien, G. and Barlow, D. (1983). Self-help manual for agoraphobia: preliminary report of effectiveness. Behavior Therapy 14, 545–556.CrossRefGoogle Scholar
Jacobson, N., Wilson, L. and Tupper, C. (1988). The clinical significance of treatment gains resulting from exposure-based interventions for agoraphobia: a reanalysis of outcome data. Behavior Therapy 19, 539–554.CrossRefGoogle Scholar
Jannoun, L., Munby, M., Catalan, J. and Gelder, M. (1980). A home-based treatment program for agoraphobia: replication and controlled evaluation. Behavior Therapy 11, 294–305.CrossRefGoogle Scholar
Jansson, L. and Öst, L. (1982). Behavioral treatments for agoraphobia: an evaluative review. Clinical Psychological Review 2, 311–337.CrossRefGoogle Scholar
Lelliott, P., Marks, I., Monteiro, W. and Tsakiris, F. (1987). Agoraphobics 5 years after imipramine and exposure: outcome and predictors. Journal of Nervous and Mental Disease 175, 599–605.CrossRefGoogle ScholarPubMed
Marks, I. (1971). Phobic disorders four years after treatment. British Journal of Psychiatry 118, 683–688.CrossRefGoogle ScholarPubMed
Marks, I. (1986). Behavioural Psychotherapy. Maudsley Pocket Book of Clinical Management. Bristol: Wright.Google Scholar
Marks, I. (1987). Fears, Phobias, and Rituals. New York: Oxford University Press.Google Scholar
Marks, I., Gray, S., Cohen, D., Hill, R., Mawson, D., Ramm, E. and Stern, R. (1983). Imipramine and brief therapist-aided in agoraphobics having self-exposure homework. Archives of General Psychiatry 40, 153–162.CrossRefGoogle ScholarPubMed
Marks, I. and Mathews, A. (1979). Brief standard self-rating for phobic patients. Behaviour Research and Therapy 17, 263–267.CrossRefGoogle ScholarPubMed
Marks, I. and Sullivan, G. (1988). Drugs and psychological treatments for agoraphobia/panic and obsessive-compulsive disorders: a review. British Journal of Psychiatry 153, 650–658.CrossRefGoogle ScholarPubMed
Marks, I. and Sullivan, G. (1989). Anti-anxiety drug and psychological treatment effects in agoraphobia/panic and obsessive-compulsive disorders. In Tyrer, P. (Ed). Psychopharmacology of Anxiety. Oxford: Oxford University Press.Google Scholar
Marks, I., Viswanathan, R., Lipsedge, M. and Gardner, R. (1972). Enhanced relief of phobias by flooding during vaning diazepam effect. British Journal of Psychiatry 121, 493–505.CrossRefGoogle Scholar
Mathews, A., Gelder, M. and Johnston, D. (1981). Agoraphobia: Nature and Treatment. New York: Guilford Press.Google Scholar
Mavissakalian, M. (1982). Pharmacological treatment of anxiety disorders. Journal of Clinical Psychiatry 43, 487–491.Google ScholarPubMed
Mavissakalian, M. (1987). The placebo effect in agoraphobia. The Journal of Nervous and Mental Disease 175, 95–99.CrossRefGoogle ScholarPubMed
Mavissakalian, M. (1988). The relationship between panic, phobic and anticipatory anxiety in agoraphobia. Behaviour Research and Therapy 26, 235–240.CrossRefGoogle ScholarPubMed
Mavissakalian, M. and Barlow, D. (1981). Phobia: Psychological and Pharmacological Treatment. New York: Guilford Press.Google Scholar
Mavissakalian, M. and Perel, J. (1985). Imipramine in the treatment of agoraphobia: dose-response relationships. American Journal of Psychiatry 142, 1032–1036.Google ScholarPubMed
McNamee, G., O'Sullivan, G., Lelliott, P. and Marks, I. (1989). Telephone-guided treatment for housebound agoraphobics with panic disorder: exposure vs. relaxation. Behavior Therapy 20, 491–497.CrossRefGoogle Scholar
McPherson, F.M., Brougham, L. and McLaren, S. (1980). Maintenance of improvement in agoraphobic patients treated by behavioural methods - a four year followup. Behaviour Research and Therapy 18, 150–152.CrossRefGoogle Scholar
Michelson, L., Mavissakalian, M. and Marchione, K. (1988). Cognitive, behavioral, and psychophysiological treatments of agoraphobia: a comparative outcome investigation. Behavior Therapy 19, 97–120.CrossRefGoogle Scholar
Munby, M. and Johnston, D. (1981). Agoraphobia: the long-term follow-up of behavioural treatment. British Journal of Psychiatry 137, 418–427.CrossRefGoogle Scholar
Norton, G., Allen, G. and Hilton, J. (1983). The social validity of treatments for agoraphobia. Behaviour Research and Therapy 21, 393–399.CrossRefGoogle ScholarPubMed
Sheehan, D., Ballenger, J. and Jacobsen, G. (1980). Treatment of endogenous anxiety with phobic, hysterical, and hypocondriacal symptoms. Archives of General Psychiatry 37, 51–59.CrossRefGoogle Scholar
Spitzer, R. and Williams, J. (1987). Structural Clinical Interview for DSM-III-R- Upjohn Version. New York: New York State Psychiatric Institute (Biometrics Research Department).Google Scholar
Telch, M., Agras, W., Taylor, C., Roth, W. and Gallen, C. (1985). Combined pharmacological and behavioral treatment for agoraphobia. Behaviour Research and Therapy 23, 325–335.CrossRefGoogle ScholarPubMed
Vermilyea, J., Boice, R. and Barlow, D. (1984). Rachman and Hodgson (1974) a decade later: How do desynchronous response systems relate to the treatment of agoraphobia? Behaviour Research and Therapy 22, 615–621.CrossRefGoogle Scholar
Zahn, T., Insel, T. and Murphy, D. (1984). Psychophysiologic changes during pharmacological treatment of obsessive-compulsive disorder. British Journal of Psychiatry 145, 39–44.CrossRefGoogle ScholarPubMed
Zitrin, C., Klein, D., Woerner, M. and Ross, D. (1983). Treatment of phobias: I. Comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry 40, 124–139.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.